Literature DB >> 8958055

Completely allogeneic spleen cells induced cytolytic neonatal tolerance to alloantigens, but failed to establish allo-helper interactions with host T cells.

A Ramos1, M González, M López-Hoyos, R Carrió, J Merino.   

Abstract

The injection of spleen cells from F1 mice into-newborns from a parental strain results in the establishment of cytolytic tolerance to donor alloantigens and the development of a lupus-like disease. This syndrome is the consequence of the recognition by alloreactive host CD4+ T cells of discordant major histocompatibility complex (MHC) class II antigens on semi-allogeneic donor B cells. We have analysed whether completely allogeneic spleen cells are as able as semi-allogeneic spleen cells to induce cytolytic tolerance to donor alloantigens and to co-operate with alloreactive T cells for autoantibody production. BALB/c mice were injected at birth with Thy-1-depleted spleen cells from (C57BL/6 x BALB/c)F1 or C57BL/6 mice, either alone or in combination. Cytolytic tolerance was always induced, as manifested by persistence of chimerism and acceptance of skin allografts. However, only F1 semi-allogeneic B cells were activated by alloreactive host T cells to produce anti-DNA IgG antibody. The deficient co-operation between BALB/c CD4+ T cells and completely allogeneic C57BL/6 B cells was confirmed after neonatal injection of (C57BL/ 6 x BALB/c)F1(Igha) spleen cells together with C57BL/6(Ighb) spleen cells. These mice developed anti-DNA antibodies bearing only the Igha allotype. Similar results were observed in experiments of allogeneic interaction in vitro, in which BALB/c CD4+ T cells were cocultured with either (C57BL/6 x BALB/c)F1 or C57BL/6 B cells. The present results demonstrate that completely allogeneic spleen cells efficiently induced cytolytic unresponsiveness to donor alloantigens, but B cells contained in this spleen cell population were unable to establish allo-helper interactions with alloreactive CD4+ T cells, suggesting that cytolytic and helper T-cell interactions involved in alloreactivity may be different.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958055      PMCID: PMC1456564          DOI: 10.1046/j.1365-2567.1996.d01-763.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

Review 1.  Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction.

Authors:  A S Rosenberg; A Singer
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

2.  Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.

Authors:  S Schurmans; G Brighouse; G Kramer; L Wen; S Izui; J Merino; P H Lambert
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

3.  On the complexity of self.

Authors:  S Rath; P Preston-Hurlburt; D B Murphy; C A Janeway
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

Review 4.  The molecular basis of allorecognition.

Authors:  L A Sherman; S Chattopadhyay
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

5.  In vivo effects of anti-IL-4 monoclonal antibody on neonatal induction of tolerance and on an associated autoimmune syndrome.

Authors:  S Schurmans; C H Heusser; H Y Qin; J Merino; G Brighouse; P H Lambert
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

6.  Self-limited autoimmune disease related to transient donor B cell activation in mice neonatally injected with semi-allogeneic F1 cells.

Authors:  M de la Hera; A de la Hera; A Ramos; L Buelta; J L Alonso; V Rodriguez-Valverde; J Merino
Journal:  Int Immunol       Date:  1992-01       Impact factor: 4.823

7.  Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.

Authors:  A Ramos; R Merino; J Merino
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

8.  Autoimmune syndrome after induction of neonatal tolerance to I-E antigens.

Authors:  A L Gonzalez; C Conde; C Revilla; A Ramos; B Renedo; J Merino
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

9.  Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors.

Authors:  K F Lindahl; D B Wilson
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

10.  Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-E alpha chain.

Authors:  R Merino; M Iwamoto; L Fossati; P Muniesa; K Araki; S Takahashi; J Huarte; K Yamamura; J D Vassalli; S Izui
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more
  1 in total

1.  Different roles for LFA-1 and VLA-4 integrins in T-B-cell interactions in vivo.

Authors:  M López-Hoyos; C Revilladagger; C Conde; E G Del Campo; A González; J Merino
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.